Targeting tauopathy with engineered tau-degrading intrabodies
Abstract Background The accumulation of pathological tau is the main component of neurofibrillary tangles and other tau aggregates in several neurodegenerative diseases, referred to as tauopathies. Recently, immunotherapeutic approaches targeting tau have been demonstrated to be beneficial in decrea...
Main Authors: | Gilbert Gallardo, Connie H. Wong, Sara M. Ricardez, Carolyn N. Mann, Kent H. Lin, Cheryl E. G. Leyns, Hong Jiang, David M. Holtzman |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-10-01
|
Series: | Molecular Neurodegeneration |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13024-019-0340-6 |
Similar Items
-
Degradation and Transmission of Tau by Autophagic-Endolysosomal Networks and Potential Therapeutic Targets for Tauopathy
by: Shanya Jiang, et al.
Published: (2020-10-01) -
Glial contributions to neurodegeneration in tauopathies
by: Cheryl E. G. Leyns, et al.
Published: (2017-06-01) -
Tau exhibits unique seeding properties in globular glial tauopathy
by: Dah-eun Chloe Chung, et al.
Published: (2019-03-01) -
Tau Spreading Mechanisms; Implications for Dysfunctional Tauopathies
by: Almudena Fuster-Matanzo, et al.
Published: (2018-02-01) -
The Role of Microglia in the Spread of Tau: Relevance for Tauopathies
by: Juan R. Perea, et al.
Published: (2018-07-01)